References
- 1. P. Khadka, J. Ro, H. Kim, I. Kim, J. T. Kim, H. Kim, J. M. Cho, G. Yun and J. Lee, Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability, Asian J. Pharm. Sci.9 (2014) 304–316; https://doi.org/10.1016/j.ajps.2014.05.005
- 2. K. T. Savjani, A. Gajjar and J. K. Savjani, Drug solubility: Importance and enhancement techniques, International Scholarly Research Network, ISRN Pharm.12 (2012). Article ID 195727; http://dx.doi.org/10.5402/2012/195727
- 3. A. Kotar, M. Kotar, P. Šket and J. Plavec, Potential of solid-state NMR and SEM in characterization of tablets of ibuprofen, Curr. Pharm. Anal.11 (2015) 124–130; https://doi.org/10.2174/1573412910666141111231325
- 4. A. G. Martinez, B. E. Rodrigez, A. P. Roca and A. M. Ruiz, Intravenous ibuprofen for treatment of post-operative pain: A multicenter, double blind, placebo-controlled, randomized clinical trial, Plos One11 (2016) 1–16; https://doi.org/10.1371/journal.pone.0154004
- 5. J. Nerurkar, J. W. Beach, M. O. Park and H. W. Jun, Solubility of (±)-ibuprofen and S(+)-ibuprofen in the presence of cosolvents and cyclodextrins, Pharm. Dev. Technol.10 (2005) 413–421; https://doi.org/10.1081/PDT-54446
- 6. A. R. Fernandes, N. R. Ferreira, J. F. Fangueiro, A. C. Santos, F. J. Veiga, C. Cabral, A. M. Silva and E. B. Souto, Ibuprofen nanocrystals developed by 22 factorial design experiment: A new approach for poorly water-soluble drugs, Saudi Pharm. J.25 (2017) 1117–1124; https://doi.org/10.1016/j.jsps.2017.07.004
- 7. K. Stoyanova, Z. Vinarov and S. Tcholakova, Improving ibuprofen solubility by surfactant-facilitated self-assembly into mixed micelles, J. Drug. Deliv. Sci. Tec.36 (2016) 208–215; https://doi.org/10.1016/j.jddst.2016.10.011
- 8. A. Tan, N. G. Eskandar, S. Rao and C. A. Prestidge, First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: A phase I study with ibuprofen, Drug. Deliv. Trans. Re.4 (2014) 212–221; https://doi.org/10.1007/s13346-013-0172-9
- 9. S. G. Potta, S. Minemi, R. K. Nukala, C. Peinado, D. A. Lamprou, A. Urquhart and D. Douroumis, Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility, J. Microencapsul. 28 (2011) 74–81; http://doi.org/10.3109/02652048.2010.529948
- 10. S. Melzig, D. Niedbalka, C. Schilde and A. Kwade, Spray drying of amorphous ibuprofen nanoparticles for the production of granules with enhanced drug release, Colloids Surf. A Physicochem. Eng. Asp.536 (2018) 133–141; https://doi.org/10.1016/j.colsurfa.2017.07.028
- 11. D. Bolten, R. Lietzow and M. Türk, Solubility of ibuprofen, phytosterol, salicylic acid, and naproxen in aqueous solutions, Chem. Eng. Technol.36 (2013) 426–434; https://doi.org/10.1002/ceat.201200510
- 12. A. A. Mamun, A. Masum, F. Sharmin, A. Islam and S. Reza, Enhancement of solubility and dissolution characteristics of ibuprofen by solid dispersion technique, Dhaka University, J. Pharm. Sci.11 (2012) 1–6; https://doi.org/10.3329/dujps.v11i1.12480
- 13. M. M. Gupta, M. G. Patel, N. S. Patel and M. Kedawat, Enhancement of dissolution rate of ibuprofen by preparing solid dispersion using different methods, Int. J. Pharm. Pharm. Sci.3 (2011) 204–206.
- 14. R. P. Dugar, B. Y. Gajera and R. H. Dave, Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407, AAPS PharmSciTech.17 (2016) 1428–1440; http://doi.ord/10.1208/s12249-016-0482-6
- 15. M. Dixit, P. Kulkarni, P. Selvam and S. Mohsin, Preparation and characterization of freeze dried crystals of ibuprofen, Int. Res. J. Pharm.2 (2011) 255–258.
- 16. Karsono, J. Tanuwijaya and D. Fatma, Formulation of ibuprofen orally disintegrating tablets (ODTs) by lyophilization method using gelatin and mannitol, Int. J. PharmTech. Res.6 (2014) 996–1002.
- 17. M. Di Cagno, P. C. Stein, N. Skalko-Basnet, M. Brandl and A. Bauer-Brandl, Solubilization of ibuprofen with β-cyclodextrin derivatives: Energetic and structural studies, J. Pharm. Biomed. Anal.55 (2011) 446–451; https://doi.org/10.1016/j.jpba.2011.02.022
- 18. K. Kagkadis, D. M. Rekkas, P. Dallas and N. H. Choulis, A freeze-dried injectable form of ibuprofen: development and optimisation using response surface methodology, PDA J. Pharm. Sci. Technol.50 (1996) 317–323; https://doi.org/10.1016/S0378-5173(97)00332-3
- 19. S. K. Patel, D. Kumar, A. P. Waghmode and A. S. Dhabale, Solubility enhancement of ibuprofen using hydrotopic agents, Int. J. Pharm. Life Sci.2 (2011) 542–545.
- 20. S.-H. Park and H.-K. Choi, The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs, Int. J. Pharm.321 (2006) 35–41; https://doi.org/10.1016/j.ijpharm.2006.05.004
- 21. S. H. Soltanpour and A. Jouyban, Solubility of acetaminophen and ibuprofen in binary and ternary mixtures of polyethylene glycols 200 and 400, propylene glycol, and water at 25 °C, Chem. Eng. Commun.201 (2014) 1606–1619; https://doi.org/10.1080/00986445.2013.821609
- 22. M. A. Filippa and E. I. Gasull, Ibuprofen solubility in pure organic solvents and aqueous mixtures of cosolvents: Interactions and thermodynamic parameters relating to the solvation process, Fluid Phase Equilibr.354 (2013) 185–190; https://doi.org/10.1016/j.fluid.2013.06.032
- 23. M. G. Volonte, P. D. Valora, A. Cingolani and M. Ferrara, Stability of ibuprofen in injection solutions, Am. J. Health-Syst. Ph.62 (2005) 630–633.
- 24. T. Lee and Y. W. Wang, Initial salt screening procedures for manufacturing ibuprofen, Drug Dev. Ind. Pharm.35 (2009) 555–567; https://doi.org/10.1080/03639040802459452
- 25. U.S. Food and Drug Administration; FDA Approved Drugs; Ibuprofen http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=ibuprofen&SearchType=BasicSearch; access date April 2017.
- 26. The ABDA – Federal Union of German Associations of Pharmacists; access date April 2017.
- 27. Highlights of prescribing information; NDA 022348 Caldolor; https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022348s010lbl.pdf; access date May 25, 2018.
- 28. J. Manrique and F. Martinez, Solubility of ibuprofen in some ethanol + water cosolvent mixtures at several temperatures, Lat. Am. J. Pharm.26 (2007) 344–354.
- 29. M. L Hart, D. P Do, R. A Ansari and S.A A. Rizvi, Brief overview of various approaches to enhance drug solubility, J. Dev. Drugs2 (2013) 1–7; https://doi.org/10.4172/2329-6631.1000115
- 30. J. N. Patel, D. M. Rathod, N. A. Patel and M. K. Modasiya, Techniques to improve the solubility of poorly soluble drugs, Int. J. Pharm. Life Sci.3 (2012) 1459–1469.
- 31. G. G. Z. Zhang, S. Y. L. Paspal, R. Suryanarayanan and D. J. W. Grant, Racemic species of sodium ibuprofen: Characterization and Polymorphic Relationships, J. Pharm. Sci.92 (2003) 1356–1366; https://doi.org/10.1002/jps.10393
- 32. J. C. Kasper and W. Friess, The freezing step in lyophilisation: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals, Eur. J. Pharmaceut. Biopharmaceut.78 (2011) 248–263; https://doi.org/10.1016/j.ejpb.2011.03.010
- 33. R. C. Rowe, P. J. Sheskey and M. E. Quinn, Mannitol, Sodium chloride, Dextrose and Succrose, in Handbook of Pharmaceutical Excipients (Ed. R. C. Rowe), 6th ed., Pharmaceutical Press and American Pharmacists Association, London/Washington, UK/USA 2009, pp. 426, 641, 224 and 704.
- 34. S. R.-Royo, A. Martin, A. L. Simplicio, A. Matias, G. Bansaghi and M. J. Cocero, Separation of ibuprofen enantiomers by diastereomic salt formation and antisolvente precipitation in supercritical carbon dioxide, Poster89, http://www.isasf.net/fileadmin/files/Docs/Graz/HtmlDir/Papers/P89.pdf; access date May 25, 2018
- 35. M. Geppi, S. Guccione, G. Mollica, R. Pignatello and C. Veracini, Molecular properties of ibuprofen and its solid dispersions with eudragit RL100 studied by solid state nuclear magnetic resonance, Pharm. Res. 22 (2005) 1544–1555; https://doi.org/10.1007/s11095-005-6249-5
- 36. F. G. Vogt, Characterization of pharmaceutical compounds by solid-state NMR, eMagRes.4 (2015) 255–268; https://doi.org/10.1002/9780470034590.emrstm1393
- 37. R. K. Harris, Applications of solid-state NMR to pharmaceutical polymorphism and related matters, J. Pharm. Pharmacol.59 (2007) 225–239; https://doi.org/10.1211/jpp.59.2.0009
- 38. T. Kitak, A. Dumičić, O. Planinšek, R. Šibanc and S. Srčič, Determination of solubility parameters of ibuprofen and ibuprofen lysinate, Molecules20 (2015) 21549–21568; https://doi.org/10.3390/molecules201219777
- 39. P. Bustamante, M. A. Peña and J. Barra, The modified extended Hansen method to determine partial solubility parameters of drug containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na, Int. J. Pharm.194 (2000) 117–124; https://doi.org/10.1016/S0378-5173(99)00374-9